Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus's egg?

被引:10
|
作者
Muijsers, Mariska [1 ]
Martel, An [1 ]
Van Rooij, Pascale [1 ]
Baert, Kris [2 ]
Vercauteren, Griet [1 ]
Ducatelle, Richard [1 ]
De Backer, Patrick [3 ]
Vercammen, Francis [4 ]
Haesebrouck, Freddy [1 ]
Pasmans, Frank [1 ]
机构
[1] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, B-9820 Merelbeke, Belgium
[2] Medicem NV, B-9100 Niklaas, Belgium
[3] Univ Ghent, Fac Vet Med, Dept Pharmacol Pharm & Toxicol, B-9820 Merelbeke, Belgium
[4] Ctr Res & Conservat, Royal Zool Soc Antwerp, B-2018 Antwerp, Belgium
来源
BMC VETERINARY RESEARCH | 2012年 / 8卷
关键词
BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRIDIOMYCOSIS; TRIMETHOPRIM; TROPICALIS; DECLINES; FROGS; TIME;
D O I
10.1186/1746-6148-8-175
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: The establishment of safe and effective protocols to treat chytridiomycosis in amphibians is urgently required. In this study, the usefulness of antibacterial agents to clear chytridiomycosis from infected amphibians was evaluated. Results: Florfenicol, sulfamethoxazole, sulfadiazine and the combination of trimethoprim and sulfonamides were active in vitro against cultures of five Batrachochytrium dendrobatidis strains containing sporangia and zoospores, with minimum inhibitory concentrations (MIC) of 0.5-1.0 mu g/ml for florfenicol and 8.0 mu g/ml for the sulfonamides. Trimethoprim was not capable of inhibiting growth but, combined with sulfonamides, reduced the time to visible growth inhibition by the sulfonamides. Growth inhibition of B. dendrobatidis was not observed after exposure to clindamycin, doxycycline, enrofloxacin, paromomycin, polymyxin E and tylosin. Cultures of sporangia and zoospores of B. dendrobatidis strains JEL423 and IA042 were killed completely after 14 days of exposure to 100 mu g/ml florfenicol or 16 mu g/ml trimethoprim combined with 80 mu g/ml sulfadiazine. These concentrations were, however, not capable of efficiently killing zoospores within 4 days after exposure as assessed using flow cytometry. Florfenicol concentrations remained stable in a bathing solution during a ten day period. Exposure of Discoglossus scovazzi tadpoles for ten days to 100 mu g/ml but not to 10 mu g florfenicol/ml water resulted in toxicity. In an in vivo trial, post metamorphic Alytes muletensis, experimentally inoculated with B. dendrobatidis, were treated topically with a solution containing 10 mu g/ml of florfenicol during 14 days. Although a significant reduction of the B. dendrobatidis load was obtained, none of the treated animals cleared the infection. Conclusions: We thus conclude that, despite marked anti B. dendrobatidis activity in vitro, the florfenicol treatment used is not capable of eliminating B. dendrobatidis infections from amphibians.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Experimental Education: Design and Implementation of Nikola Tesla's Egg of Columbus as an Instructional Aid
    Plyler, Damon
    Roach, Wyatt
    Domi, Xhino
    Folden, Justin
    Acacio, Robert
    Vargas, Isaac
    Meritt, Jeremy
    Damjanovic, Aleksandar
    Integlia, Ryan
    IEEE SOUTHEASTCON 2018, 2018,
  • [22] Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
    Bloom, Patricia P.
    Young, Vincent B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 89 - 101
  • [23] Repair versus replacement of the aortic valve for the treatment of active infective endocarditis: is Sorin Solo the aortic bioprosthesis Columbus's egg? Reply
    Schaefers, Hans-Joachim
    Aicher, Diana
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (06) : 1277 - 1277
  • [24] Antibacterial nanotruffles for treatment of intracellular bacterial infection
    Elnaggar, Marwa G.
    Jiang, Kunyu
    Eldesouky, Hassan E.
    Pei, Yihua
    Park, Jinho
    Yuk, Simseok A.
    Meng, Fanfei
    Dieterly, Alexandra M.
    Mohammad, Haroon T.
    Hegazy, Youssef A.
    Tawfeek, Hesham M.
    Abdel-Rahman, Aly A.
    Aboutaleb, Ahmed E.
    Seleem, Mohamed N.
    Yeo, Yoon
    BIOMATERIALS, 2020, 262 (262)
  • [25] RNAi therapeutics for the treatment of chronic hepatitis B virus infection
    Wooddell, C.
    John, M.
    Hossbach, M.
    Deckert, J.
    Hadwiger, P.
    Hamilton, H.
    Chu, Q.
    Wakefield, D.
    Klein, J.
    Vornlocher, H. -P.
    McLachlan, A.
    Rozema, D.
    Lewis, D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E48 - E48
  • [26] Ribozyme therapeutics for the treatment of HIV infection: Progress and future directions
    Rossi, J
    Lee, NS
    Bertrand, E
    Westaway, S
    Zhou, C
    Bahner, I
    Kohn, D
    Engelke, D
    Good, P
    Li, S
    Zaia, J
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1996, 21 (01) : 69 - 72
  • [27] Novel Therapeutics in Discovery and Development for Treatment of Chronic HBV Infection
    Hu, Yimin
    Zhu, Wei
    Tang, Guozhi
    Mayweg, Alexander V.
    Yang, Guang
    Wu, Jim Z.
    Shen, Hong C.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 265 - 281
  • [28] Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection
    Feng, Song
    Gao, Lu
    Han, Xingchun
    Hu, Taishan
    Hu, Yimin
    Liu, Haixia
    Thomas, Andrew W.
    Yan, Zhipeng
    Yang, Song
    Young, John A. T.
    Yun, Hongying
    Zhu, Wei
    Shen, Hong C.
    ACS INFECTIOUS DISEASES, 2018, 4 (03): : 257 - 277
  • [29] Environmental gradients explaining the prevalence and intensity of infection with the amphibian chytrid fungus: the host's perspective
    Roedder, D.
    Veith, M.
    Loetters, S.
    ANIMAL CONSERVATION, 2008, 11 (06) : 513 - 517
  • [30] A geometric treatment of Jellett's egg
    Bou-Rabee, NM
    Marsden, JE
    Romero, LA
    ZAMM-ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND MECHANIK, 2005, 85 (09): : 618 - 642